Mohammed T. Abou-Saleh

THE EPIDEMIOLOGY OF ALZHEIMER’S DISEASE: AN UPDATE 21115. Sano M, Ernesto C, Thomas RG et al. A controlled trial of selegiline,-tocopherol, or both as treatment of Alzheimer’s disease. N Engl JMed 1997; 336: 1216–22.16. Richardson SJ. Free radicals in the genesis of Alzheimer’s disease.Ann NY Acad Sci 1993; 695: 73–6.17. Markesbury WR. Oxidative stress hypothesis in Alzheimer’s disease.Free Rad Biol Med 1997; 23: 134–7.18. Grunewald RA. Ascorbic acid in the brain. Brain Res Rev 1993; 18:123–33.19. Frei B, Stocker R, Ames BN. Antioxidant defences and lipidperoxidation in human blood plasmas. Proc Nat Acad Sci 1988; 85:9748–52.20. Kristenson M, Zieden B, Kucinskiene Z et al. Antioxidant state andmortality from coronary heart disease in Lithuanian and Swedishmen: concomitant cross sectional study of men aged 50. Br Med J1997; 314: 629–33.21. Nyyssonen K, Parviainen MT, Salonen R et al. Vitamin C deficiencyand risk of myocardial infarction: prospective population study ofmen from eastern Finland. Br Med J 1997; 314: 634–8.22. Rimm E, Willett WC, Hu FB et al. Folate and vitamin B 6 from dietand supplements in relation to risk of coronary heart disease amongwomen. J Am Med Assoc 1998; 279: 359–64.23. Lishman WA. Alcohol and the brain. Br J Psychiat 1990; 156: 635–44.24. Lishman WA. Vitamin deficiencies. In Organic Psychiatry, 3rd edn.London: Blackwell Scientific, 1998; 570–93.25. Watson R. Undernutrition, weight loss and feeding difficulty inelderly patients with dementia: a nursing perspective. Rev ClinGerontol 1997; 7: 317–26.